|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/26 | |
| A61K 38/28 | |||
| A61P 3/10 | |||
| A61P 5/50 |
| (11) | Patento numeris | 2575865 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11723919.4 |
| Europos patento paraiškos padavimo data | 2011-05-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-04-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-12-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/058764 |
| Data | 2011-05-27 |
| (87) | Numeris | WO 2011/147980 |
| Data | 2011-12-01 |
| (30) | Numeris | Data | Šalis |
| 10164368 | 2010-05-28 | EP |
| (72) |
BECKER, Reinhard, DE
HAUCK, Gerrit, DE
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
| (54) | Pharmaceutical Composition Comprising AVE0010 and Insulin Glargine |
| Pharmaceutical Composition Comprising AVE0010 and Insulin Glargine |